Selective p300 Degradation via Peptide PROTAC: A New Therapeutic Strategy for Advanced Prostate Cancers
Favorite
Share
More Options
2

Open in WPS to view all 2 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
